Fixed-dose combination of nebivolol and valsartan in patients with stage 1 or 2 hypertension: ABPM substudy of a phase 3 randomized trial

Plasma renin activity and aldosterone levels in patients with hypertension receiving fixed-dose combination of nebivolol and valsartan: substudy of a phase 3 randomized trial

Journal of the American Society of Hypertension ◽

10.1016/j.jash.2014.03.063 ◽

2014 ◽

Vol 8 (4) ◽

pp. e33

Author(s):

Thomas D. Giles ◽

George Bakris ◽

Suzanne Oparil ◽

Michael A. Weber ◽

Wei Chen ◽

...

Keyword(s):

Plasma Renin Activity ◽

Randomized Trial ◽

Plasma Renin ◽

Renin Activity ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Phase 3 ◽

Phase 3 randomized, controlled clinical trial of bictegravir coformulated with FTC/TAF in a fixed-dose combination (B/F/TAF) vs dolutegravir (DTG) + F/TAF in treatment-naïve HIV-1 positive adults: week 48 results

10.26226/morressier.5aeaf2d35800a00019097f85 ◽

2018 ◽

Author(s):

Christian Wisskirchen ◽

Hans-Jürgen Stellbrink

Keyword(s):

Clinical Trial ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Controlled Clinical Trial ◽

Randomized Controlled Clinical Trial ◽

Phase 3 ◽

Randomized Controlled ◽

Treatment Naïve ◽

Dose Combination ◽

Hiv 1

Faculty Opinions recommendation of Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725431366.793505980 ◽

2015 ◽

Author(s):

Philip Rosenthal

Keyword(s):

Hepatitis C ◽

Japanese Patients ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Genotype 1 ◽

Open Label ◽

Phase 3 ◽

Treatment Naïve ◽

Dose Combination ◽

Previously Treated

Efficacy of Olmesartan Medoxomil and Hydrochlorothiazide Fixed-Dose Combination Therapy in Patients Aged 65 Years and Older with Stage 1 and 2 Hypertension or Isolated Systolic Hypertension

American Journal of Cardiovascular Drugs ◽

10.2165/11635000-000000000-00000 ◽

2012 ◽

Vol 12 (5) ◽

pp. 325-333 ◽

Author(s):

F. Wilford Germino ◽

Joel M. Neutel ◽

Robert Dubiel ◽

Jen-Fue Maa ◽

Kathleen J. Chavanu

Keyword(s):

Combination Therapy ◽

Systolic Hypertension ◽

Olmesartan Medoxomil ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Isolated Systolic Hypertension ◽

Dose Combination ◽

Stage 1

Efficacy and safety of azilsartan medoxomil/chlortalidone fixed-dose combination in hypertensive patients uncontrolled on azilsartan medoxomil alone: A randomized trial

Journal of Clinical Hypertension ◽

10.1111/jch.13376 ◽

2018 ◽

Vol 20 (10) ◽

pp. 1473-1484 ◽

Author(s):

David J. Collier ◽

Attila Juhasz ◽

Enrico Agabiti-Rosei ◽

Eric Lloyd ◽

Michie Hisada ◽

...

Keyword(s):

Randomized Trial ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Efficacy And Safety ◽

Hypertensive Patients ◽

Dose Combination ◽

Azilsartan Medoxomil

Fixed-Dose Combination of Netarsudil and Latanoprost in Ocular Hypertension and Open-Angle Glaucoma: Pooled Efficacy/Safety Analysis of Phase 3 MERCURY-1 and -2

Advances in Therapy ◽

10.1007/s12325-020-01277-2 ◽

2020 ◽

Vol 37 (4) ◽

pp. 1620-1631 ◽

Cited By ~ 4

Author(s):

Sanjay Asrani ◽

Jason Bacharach ◽

Edward Holland ◽

Hayley McKee ◽

Huan Sheng ◽

...

Keyword(s):

Ocular Hypertension ◽

Open Angle Glaucoma ◽

Safety Analysis ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Open Angle ◽

Phase 3 ◽

O109 ALL ORAL FIXED-DOSE COMBINATION SOFOSBUVIR/LEDIPASVIR WITH OR WITHOUT RIBAVIRIN FOR 12 OR 24 WEEKS IN TREATMENT-EXPERIENCED GENOTYPE 1 HCV-INFECTED PATIENTS: THE PHASE 3 ION-2 STUDY

Journal of Hepatology ◽

10.1016/s0168-8278(14)60111-2 ◽

2014 ◽

Vol 60 (1) ◽

pp. S45 ◽

Author(s):

N. Afdhal ◽

R.K. Reddy ◽

P. Pockros ◽

A.M. Di Bisceglie ◽

S. Arora ◽

...

Keyword(s):

Fixed Dose Combination ◽

Fixed Dose ◽

Genotype 1 ◽

Phase 3 ◽

A Randomized Trial of Fixed-Dose Combination Brinzolamide 1%/Brimonidine 0.2% as Adjunctive Therapy to Travoprost 0.004%

American Journal of Ophthalmology ◽

10.1016/j.ajo.2016.02.026 ◽

2016 ◽

Vol 165 ◽

pp. 188-197 ◽

Cited By ~ 5

Author(s):

Robert M. Feldman ◽

Gregory Katz ◽

Matthew McMenemy ◽

Douglas A. Hubatsch ◽

Tony Realini

Keyword(s):

Randomized Trial ◽

Adjunctive Therapy ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Tu2038 All Oral Fixed-dose Combination Sofosbuvir/Ledipasvir With or Without Ribavirin for 12 or 24 Weeks in Treatment-Naive Genotype 1 HCV-Infected Patients: The Phase 3 ION-1 Study

Gastroenterology ◽

10.1016/s0016-5085(14)63284-4 ◽

2014 ◽

Vol 146 (5) ◽

pp. S-903 ◽

Author(s):

Ira M. Jacobson ◽

Patrick Marcellin ◽

Alessandra Mangia ◽

Paul Y. Kwo ◽

Graham Foster ◽

...

Keyword(s):

Fixed Dose Combination ◽

Fixed Dose ◽

Genotype 1 ◽

Phase 3 ◽

Treatment Naïve ◽

Efficacy and Tolerability of a Fixed-Dose Combination of Rosuvastatin and Ezetimibe Compared with a Fixed-Dose Combination of Simvastatin and Ezetimibe in Brazilian Patients with Primary Hypercholesterolemia or Mixed Dyslipidemia: A Multicenter, Randomized Trial

Current Therapeutic Research ◽

10.1016/j.curtheres.2020.100595 ◽

2020 ◽

Vol 93 ◽

pp. 100595

Author(s):

Antonio Carlos Amedeo Vattimo ◽

Francisco Antonio Helfestein Fonseca ◽

Douglas Costa Morais ◽

Larissa Fontes Generoso ◽

Renata Herrera ◽

...

Keyword(s):

Randomized Trial ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Primary Hypercholesterolemia ◽

Multicenter Randomized Trial ◽

Mixed Dyslipidemia ◽